Cargando…
The Use of Off-Label Medications in Newborn Infants Despite an Approved Alternative Being Available—Results of a National Survey
Neonates continue to be treated with off-label or unlicensed drugs while in hospital. However, some medications that have previously been used in adults underwent clinical testing and licensure for use with a different indication in the neonatal and pediatric population. Almost always, the marketing...
Autores principales: | Veldman, Alex, Richter, Eva, Hacker, Christian, Fischer, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877519/ https://www.ncbi.nlm.nih.gov/pubmed/35202069 http://dx.doi.org/10.3390/pharmacy10010019 |
Ejemplares similares
-
Ciprofloxacin Use in Hospitalized Children: Approved or Off-label?
por: Faghihi, Toktam, et al.
Publicado: (2017) -
Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options
por: Isidro, Maria Luisa, et al.
Publicado: (2010) -
Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card
por: Sarsour, Khaled, et al.
Publicado: (2020) -
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines
por: Zarkavelis, G., et al.
Publicado: (2022) -
Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
por: dos Santos, Laura Goedel, et al.
Publicado: (2023)